Awardee OrganizationSTATE UNIVERSITY NEW YORK STONY BROOK
Description
Abstract Text
Project Summary
Many cells can travel from one place to another. This nomadic cell behavior is harnessed to form organs, seal
wounds, and hunt down pathogens, but it is often dysregulated in human diseases, including cancer.
Consequently, understanding the molecular basis of cell movement has widespread significance for human
health. Decades of cell migration studies have outlined how a cell moves on a flat surface. In a two-dimensional
environment, a moving cell extends a branched actin-filled protrusion in the direction of movement, while
actomyosin contractility retracts the rear. However, cells can move without actin-filled protrusions in vivo using
a poorly understood, three-dimensional migration mode called amoeboid migration. Amoeboid migrating cells
can move by extruding pressure-filled blebs devoid of actin or rapidly migrate with a near-constant spherical
shape using cortical actin flow. Cortical flow-driven amoeboid migration is commonly referred to as fast amoeboid
migration (FAM) and is induced by mechanical confinement in a wide variety of cells, with an increased
propensity in invasive cancer cells. The non-genetic and extensive induction of FAM, coupled with its use by
cancer cells in vivo, necessitates a mechanistic understanding of its underpinnings. However, observing and
perturbing FAM is technically challenging in vivo, and the plasticity with which cells can switch how they migrate
can confound subsequent analysis. My lab uses the developmental migration of Drosophila primordial germ cells
(PGCs) as a facile, reproducible system to study FAM. PGCs natively use FAM in vivo and, importantly, maintain
the characteristic cortical actin flows that power FAM outside of the embryo in culture without mechanochemical
inputs. Thus, PGCs do not alter how they move, even in a foreign two-dimensional environment. Over the next
five years, we will capitalize on the inflexible nature of migratory PGCs to deconstruct FAM and address several
outstanding, currently intractable questions: (1) What cortical actin architectures are permissive for cortical flows,
and how are these networks assembled, regulated, and maintained? (2) How are cortical flows oriented by
guidance cues to direct FAM? (3) How are cortical flows transmitted to a given substrate to generate traction for
productive motility? Results from this study will shed light on a poorly understood cell migration strategy and will
identify key factors to not only halt it for therapeutic intervention but also endow other cells with its use for cell-
based therapies.
Public Health Relevance Statement
Project Narrative
Understanding how cells move lies at the heart of combating debilitating diseases like cancer. While cells
typically extend actin-rich protrusions to move in culture, cells in developing organisms and tumors can move
without them. The research proposed here uses a developmental model to understand how alternative forms of
cell movement function and will improve human health by identifying new therapeutic targets to stop malignant
cell migration.
NIH Spending Category
No NIH Spending Category available.
Project Terms
3-DimensionalActinsActomyosinAddressArchitectureBullaCell TherapyCellsCharacteristicsCoupledCuesDevelopmentDiseaseDrosophila genusEmbryoEndowmentEnvironmentHealthHeartHumanMalignant NeoplasmsMechanicsModelingMolecularMotilityMovementNatureOrganOrganismProductivityReproducibilityResearchShapesStructure of primordial sex cellSurfaceSystemTherapeutic InterventionTractionTravelcancer cellcancer invasivenesscell behaviorcell motilityhuman diseaseimprovedin vivomigrationnew therapeutic targetnon-geneticpathogenpermissivenesspressuresealtransmission processtumortwo-dimensionalwound
No Sub Projects information available for 1R35GM157022-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R35GM157022-01
Patents
No Patents information available for 1R35GM157022-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R35GM157022-01
Clinical Studies
No Clinical Studies information available for 1R35GM157022-01
News and More
Related News Releases
No news release information available for 1R35GM157022-01
History
No Historical information available for 1R35GM157022-01
Similar Projects
No Similar Projects information available for 1R35GM157022-01